Dr. Pyrsopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
435 South St
Ste 230A
Morristown, NJ 07960Phone+1 973-971-7507Fax+1 973-290-7130
Summary
- Nikolaos Pyrsopoulos, MD, PhD, MBA, FACP, FACG, AGAF, FAASLD, FRCP currently serves as Professor at NYU and Regional Director Liver Disease in New Jersey. He completed his medical degrees (MD and PhD) at the University of Athens in Greece, followed by residency and fellowships in Athens and the University of Miami School Of Medicine. He has been board certified in the areas of Internal Medicine, Gastroenterology and Transplant Hepatology. He received his M.B.A. from the University of Miami School Of Business. He has publications in various scientific journals, including the Journal of Gastroenterology, Hepatology and Transplantation and is one of the authors in the book devoted to the unique field of abdominal transplantation: Intestinal and Multivisceral Transplantation. In addition, he currently serves as one of the Chief editors for the World Journal of Hepatology and he is on the Editorial Board for the Journal of Clinical and Translational Hepatology, Gastrointestinal Endoscopy, and other well‐known journals in the field of Hepatology and Gastroenterology. He is a Fellow of The American College of Physicians, American Gastroenterological Association, and the American Association of the Study of Liver Diseases. He is alsoa member of various medical associations such the European Association of the Study of the Liver, the American Society of Gastrointestinal Endoscopy and the American Society of Transplantation, among others. He has served in numerous national and institutional committees. In addition, he served as the Region 2 Review Board Chair for UNOS. Dr. Pyrsopoulos has participated in international and national research projects. He was the Rutgers NJMS Faculty Organization and RBHS president. His vision is excellence in patient care, providing outstanding education to the fellows, residents and students and promoting the science of medicine by conducting research.
Education & Training
- University of Miami School of Business AdministrationMBA, 2009
- University of Miami/Jackson Health SystemFellowship, Gastroenterology, 2003 - 2005
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2003
- University of Miami/Jackson Health SystemFellowship, Transplant Hepatology, 1998 - 2001
- University of AthensClass of 1991
- University of AthensPhD, Fulminant Hepatic Failure
Certifications & Licensure
- FL State Medical License 2003 - 2026
- NJ State Medical License 2013 - 2025
- NY State Medical License 2023 - 2025
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding Start of enrollment: 2018 Jul 01
- A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Start of enrollment: 2014 May 01
- A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension Start of enrollment: 2014 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsEmricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With PlaceboCatherine Frenette, Giuseppe Morelli, Mitchell L. Shiffman, R. Todd Frederick, Raymond A. Rubin
Clinical Gastroenterology and Hepatology. 2019-03-01 - 57 citationsEmricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension.Guadalupe Garcia-Tsao, Michael Fuchs, Mitchell L. Shiffman, Brian B. Borg, Nikolaos Pyrsopoulos
Hepatology. 2019-02-01 - 35 citationsEmricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, Parvez S. Mantry, Kathryn J. Lucas
Journal of Hepatology. 2021-02-01
Journal Articles
- Microbiota and the LiverNikolaos Pyrsopoulos, MD, Liver transplantation
Other
- Are you at risk for liver disease?N Pyrsopoulos
http://video.foxnews.com/v/3202782981001/are-you-at-risk-for-liver-disease/#sp=show-clips
Press Mentions
- Mallinckrodt to Present Data on TERLIVAZ® (Terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific MeetingOctober 24th, 2022
- Rutgers Colonoscopy Expert Available to Discuss New Efficacy StudyOctober 13th, 2022
- University Hospital Liver Transplant Program Remains No. 1 Program in the Tri-StateAugust 5th, 2021
- Join now to see all
Committees
- Member, Nominating committee, AGA 2018 - Present
- Member, Financial committee, AASLD 2017 - Present
- Councillor, Liver and Biliary, AGA 2017 - Present
Professional Memberships
- Fellow
- Fellow
- Member
- Member
- American Association for the Study of Liver DiseasesMember
- European Association for the Study of the LiverMember
- International Association for the Study of the Liver (IASL)Member
- American Society of Transplantation (AST)Member
- International Liver Transplantation SocietyMember
Other Languages
- Greek, French, Spanish
External Links
- 1st Annual Update on Liver Diseases http://ccoe.rbhs.rutgers.edu/catalog/courses/pdf/14mn07.pdf
- Digestive Diseases updatehttp://ccoe.rbhs.rutgers.edu/catalog/courses/pdf/15MN01.pdf
- 2nd Annual Update on Liver Diseases http://ccoe.rbhs.rutgers.edu/catalog/courses/pdf/15MN09.pdf
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: